Search results
22 kwi 2024 · Fluorescence in situ hybridization (FISH) is a technique pathologists use in genetic testing to help diagnose diseases caused by chromosomal differences. Healthcare providers can also use FISH to detect gene changes that they can target to treat cancer.
Bone marrow aspirate and biopsy with fluorescence in situ hybridization (FISH) testing for relevant markers should be performed as clinically indicated, including upon diagnosis and in low-/standard-risk individuals at time of relapse to aid in risk stratification.
28 mar 2024 · A HER2 FISH (Fluorescence In Situ Hybridization) test is done on breast cancer tissue removed during biopsy to see whether the cells have extra copies of the HER2 gene.
Fluorescence in situ hybridization (FISH) is a molecular cytogenetic technique that uses fluorescent probes that bind to only particular parts of a nucleic acid sequence with a high degree of sequence complementarity.
22 kwi 2024 · FISH, or fluorescence in situ hybridization, is used for understanding the genetic makeup of myeloma; it focuses on treatment patterns and outcomes. This test, conducted on bone marrow biopsy samples, utilizes fluorescent dyes to map out genetic material, identifying chromosome changes such as deletions or translocations.
The interpretation of FISH results should include consideration of the reason for referral for testing and, when available, additional laboratory findings including conventional cytogenetic analysis, histology, and immunophenotype. 12
17 kwi 2020 · Fluorescence in situ hybridization (FISH) is a standard technique used in routine diagnostics of genetic aberrations. Thanks to simple FISH procedure is possible to recognize tumor-specific abnormality. Its applications are limited to designed probe type.
